Thomas Dülffer
Impact in
-
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Metabolomics and Mass Spectrometry Studies 2
- Chemical Synthesis and Analysis 2
-
- Antimicrobial Resistance in Staphylococcus 1
- Co-authors
- Uwe Kobold (5 shared papers)Kor Miedema (1 shared paper)Wieland Hoelzel (1 shared paper)Jan‐Olof Jeppsson (1 shared paper)Andreas Finke (1 shared paper)Andreas Leinenbach (2 shared papers)Johan Gobom (1 shared paper)Henrik Zetterberg (1 shared paper)
- Journals
- Clinical Chemistry (2 papers)Analytical and Bioanalytical Chemistry (1 paper)Clinical Chemistry and Laboratory Medicine (CCLM) (1 paper)Advances in experimental medicine and biology (1 paper)Journal of Chromatography B Biomedical Sciences and Applications (1 paper)
- Partner nations
- GermanySwedenUnited Kingdom
In The Last Decade
Thomas Dülffer
8 papers receiving 328 citations
Peers
Comparison fields: 5 of 82
- Endocrinology, Diabetes and Metabolism 86
- Clinical Biochemistry 35
- Physiology 106
- Psychiatry and Mental health 58
- Spectroscopy 59
Countries citing papers authored by Thomas Dülffer
This map shows the geographic impact of Thomas Dülffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Dülffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Dülffer more than expected).
Fields of papers citing papers by Thomas Dülffer
This network shows the impact of papers produced by Thomas Dülffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Dülffer. The network helps show where Thomas Dülffer may publish in the future.
Co-authors
The 23 scholars most cited alongside Thomas Dülffer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 146 | |
| 2 | 2014 | 114 | |
| 3 | 2013 | 35 | |
| 4 | 1992 | 21 | |
| 5 | 1977 | 11 | |
| 6 | 2012 | 9 | |
| 7 | The use of 2-iminothiolane as a protein crosslinking reagent. | 1977 | 4 |
| 8 | The synthesis of a cleavable and hydrophilic cross-linking reagent. | 1976 | 1 |
About Thomas Dülffer
Thomas Dülffer is a scholar working on Molecular Biology, Infectious Diseases, Organic Chemistry, Pharmacology and Cell Biology, having authored 8 papers that have together received 341 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (2 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Chemical Synthesis and Analysis (2 papers), Synthetic Organic Chemistry Methods (1 paper), Analytical Methods in Pharmaceuticals (1 paper), Antimicrobial Resistance in Staphylococcus (1 paper), Alzheimer's disease research and treatments (1 paper) and Analytical Chemistry and Chromatography (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (86 citations), Clinical Biochemistry (35 citations), Physiology (106 citations), Psychiatry and Mental health (58 citations) and Spectroscopy (59 citations). Thomas Dülffer has collaborated with scholars based in Germany, Sweden and United Kingdom. Frequent co-authors include Uwe Kobold, Kor Miedema, Wieland Hoelzel, Jan‐Olof Jeppsson, Andreas Finke, Andreas Leinenbach, Johan Gobom, Henrik Zetterberg, Erik Portelius and Ulf Andréasson. Their work appears in journals such as Clinical Chemistry, Analytical and Bioanalytical Chemistry, Clinical Chemistry and Laboratory Medicine (CCLM), Advances in experimental medicine and biology and Journal of Chromatography B Biomedical Sciences and Applications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.